SI — SHOULDER INNOVATIONS, INC.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1699350 ·
Last close
$16.99
Market Cap
$353.71M
52W High
$24.59
52W Low
$10.92
ADV30
119,077
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 17,175,000 | 13,441,000 | -10,036,000 | -10,153,000 | 152,007,000 | 24,460,000 | 27,679,000 |
| Mar 2026 | 16,708,000 | 12,986,000 | -8,976,000 | -8,379,000 | 160,361,000 | 11,492,000 | 27,344,000 |
| Dec 2025 | 14,416,000 | 11,057,000 | -8,500,000 | -7,772,000 | 169,907,000 | 26,871,000 | 29,157,000 |
| Sep 2025 | 11,756,000 | 8,961,000 | -7,641,000 | -8,729,000 | 177,762,000 | 54,934,000 | 29,930,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-37,088,000
Investing CF
$-72,396,000
Financing CF
$106,890,000
CapEx
$-9,989,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.92
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-115,932,000
Inventory
$22,920,000
Receivables
$10,873,000
ST Investments
$74,533,000
EBIT TTM
$-36,026,000
Pretax Income TTM
$-35,033,000
Interest Exp TTM
$70,000
Analysts
4
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 47,317,000 | -26,297,000 | -40,359,000 | 169,907,000 | 29,157,000 | 140,750,000 | -28,612,000 |
| Dec 2024 | 31,623,000 | -14,653,000 | -15,619,000 | 43,080,000 | 97,775,000 | -54,695,000 | -14,143,000 |
| Dec 2023 | 19,274,000 | -10,864,000 | -12,655,000 | 54,294,000 | 94,031,000 | -39,737,000 | -13,144,000 |
TTM Snapshot
Revenues TTM
$17,586,000
NetIncome TTM
$-8,717,000
OpCashFlow TTM
$0
Assets (Latest)
$169,907,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | $357.63M | $5.95 | — |
| RCEL | AVITA Medical, Inc. | $366.17M | $11.84 | — |
| EMBC | Embecta Corp. | $334.29M | $5.90 | — |
| CV | CapsoVision, Inc | $332.81M | $6.65 | — |
| OFIX | Orthofix Medical Inc. | $381.58M | $9.44 | — |
News headlines (Yahoo Finance, 1h cache)
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
2026-09-10 20:05 · Yahoo
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
2026-09-09 20:05 · Yahoo
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
2026-09-01 20:05 · Yahoo
Shoulder Innovations Inc (SI) (Q2 2026) Earnings Call Highlights: Revenue Surges 56% as ...
2026-08-07 05:06 · Yahoo
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook
2026-08-06 20:05 · Yahoo
Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
2026-06-29 11:00 · Yahoo
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
2026-09-08 20:05 · Yahoo
UMH Properties and 4 More Stocks See Action From Activist Investors
2026-08-14 23:05 · Yahoo
Silver could surge to $90 as investment demand takes over, Citi says
2026-08-12 11:29 · Yahoo
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
2026-08-10 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.